go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Eli Lilly and Company (Ireland) Limited
Hyde House, 65, Adelaide Road, Dublin 2,
Telephone: +353 1 661 4377
Fax: +353 1 661 4476
WWW: http://www.lilly.ie
Medical Information Direct Line: +44 (0)1256 315 000
Medical Information Facsimile: +44 (0)1256 775 569
Patient Information Leaflet last updated on medicines.ie: 04/11/2011
PIL Alimta

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 04/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 16/02/2011 and displayed until 04/11/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 01/12/2009 and displayed until 16/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change to appearance of the medicine
  • Changes to therapeutic indications
Updated on 27/02/2009 and displayed until 01/12/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 28/04/2008 and displayed until 27/02/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 06/02/2008 and displayed until 28/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change of special precautions for disposal
Updated on 05/02/2008 and displayed until 06/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change of special precautions for disposal
Updated on 02/04/2007 and displayed until 05/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Improved electronic presentation
  • Change to date of revision
Updated on 08/03/2007 and displayed until 02/04/2007
Reasons for adding or updating:
  • Improved electronic presentation
  • Change to side-effects
  • Change to date of revision
Updated on 13/03/2006 and displayed until 08/03/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 09/11/2004 and displayed until 13/03/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Pemetrexed disodium